Zhongze Therapeutics
PrivateLast Round
Pre Seed
Sep 30, 2021
Total Funding Raised
$10M
Company Overview
Zhongze Therapeutics is a clinical-stage biotechnology company that focuses on the discovery, development, and commercialization of innovative therapies for psychiatric and neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zhongze Therapeutics Comparables
Compare Zhongze Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Viage Therapeutics | 80% | |
| NeuShen Therapeutics | 79% | |
| Neurosterix | 78% | |
Zhongze Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Sep 30, 2021 |
Zhongze Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cenova Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 30, 2021
$10M round led by Cenova Capital
Zhongze Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Zhongze Therapeutics's valuation, stock price, and market status.